Related references
Note: Only part of the references are listed.Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic ( VIVALDI study): prospective cohort study in England
Maria Krutikov et al.
LANCET HEALTHY LONGEVITY (2022)
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England
Maria Krutikov et al.
LANCET GLOBAL HEALTH (2022)
Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting
Ellen C. Hughes et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
COVID-19 antibody seroprevalence in Santa Clara County, California
Eran Bendavid et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2021)
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Carlo Cervia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Frailty and comorbidity in predicting community COVID-19 mortality in the UK Biobank: The effect of sampling
Jonathan K. L. Mak et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada
Sahar Saeed et al.
TRANSFUSION (2021)
Racial and Ethnic Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: An Analysis of 45 States and the District of Columbia
Jay J. Xu et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen et al.
LANCET GLOBAL HEALTH (2021)
The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS study
Francisco Javier Candel et al.
AGE AND AGEING (2021)
Second versus first wave of COVID-19 deaths: Shifts in age distribution and in nursing home fatalities
John P. A. Ioannidis et al.
ENVIRONMENTAL RESEARCH (2021)
Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies
Kayoko Shioda et al.
EPIDEMIOLOGY (2021)
Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations
John P. A. Ioannidis
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
Shay Reicher et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors et al.
NATURE COMMUNICATIONS (2021)
Racial disparities in COVID-19 outcomes exist despite comparable Elixhauser comorbidity indices between Blacks, Hispanics, Native Americans, and Whites
Fares Qeadan et al.
SCIENTIFIC REPORTS (2021)
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Laith J. Abu-Raddad et al.
SCIENTIFIC REPORTS (2021)
Provisional Mortality Data - United States, 2020
Farida B. Ahmad et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership
David M. Herrington et al.
BMC INFECTIOUS DISEASES (2021)
Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study
Laura Espenhain et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study
Fabrice Carrat et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2021)
SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study
Ramanan Laxminarayan et al.
LANCET INFECTIOUS DISEASES (2021)
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
Heather Kalish et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic
Carmen L. Charlton et al.
MICROBIOLOGY SPECTRUM (2021)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors
Ole Birger Pedersen et al.
CLINICAL INFECTIOUS DISEASES (2021)
COVID-19 in long-term care facilities in Brazil: serological survey in a post-outbreak setting
Eliana Nogueira Castro de Barros et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2021)
Inferring the COVID-19 infection fatality rate in the community-dwelling population: a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data
Harlan Campbell et al.
EPIDEMIOLOGY AND INFECTION (2021)
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults
Helen Ward et al.
LANCET REGIONAL HEALTH-EUROPE (2021)
Precision shielding for COVID-19: metrics of assessment and feasibility of deployment
John P. A. Ioannidis
BMJ GLOBAL HEALTH (2021)
Infection fatality rate of COVID-19 inferred from seroprevalence data
John P. A. Ioannidis
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2021)
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France
Floriane Gallais et al.
EMERGING INFECTIOUS DISEASES (2021)
Innate Immune Evasion by Human Respiratory RNA Viruses
Marjolein Kikkert
JOURNAL OF INNATE IMMUNITY (2020)
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility
M. M. Arons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary
Bela Merkely et al.
GEROSCIENCE (2020)
Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic
Robert Paulino-Ramirez et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters
John P. A. Ioannidis et al.
ENVIRONMENTAL RESEARCH (2020)
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
Alberto L. Garcia-Basteiro et al.
NATURE COMMUNICATIONS (2020)
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Shuchi Anand et al.
LANCET (2020)
Humoral Immune Response to SARS-CoV-2 in Iceland
Daniel F. Gudbjartsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients
Christel Faes et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors
Antonio Vena et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
Andrew T. Levin et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Nathan Post et al.
PLOS ONE (2020)
COVID-19 Outbreak - New York City, February 29-June 1, 2020
Corinne N. Thompson et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Age-specific mortality and immunity patterns of SARS-CoV-2
Megan O'Driscoll et al.
NATURE (2020)
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
Manoj V. Murhekar et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020
Zijian Feng et al.
CHINA CDC WEEKLY (2020)
Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population-based study
Eshan U. Patel et al.
TRANSFUSION (2019)
The human antibody response to influenza A virus infection and vaccination
Florian Krammer
NATURE REVIEWS IMMUNOLOGY (2019)
Racial and Ethnic Disparities in Health Insurance Coverage: Dynamics of Gaining and Losing Coverage Over the Life-Course
Heeju Sohn
POPULATION RESEARCH AND POLICY REVIEW (2017)
Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data
Zachary Munn et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)
Research methodology - Reasons or excuses for avoiding meta-analysis in forest plots
John P. A. Ioannidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)